financetom
Business
financetom
/
Business
/
Morgan Stanley expects mergers, IPOs to lag trends through 2024
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morgan Stanley expects mergers, IPOs to lag trends through 2024
Sep 10, 2024 11:58 PM

NEW YORK, Sept 10 (Reuters) - Morgan Stanley ( MS ) expects

activity for mergers, acquisitions and initial public offerings

to remain below trends for the rest of the year, its

co-president Dan Simkowitz said on Tuesday.

Activity will probably pick up next year as central banks

cut interest rates, said Simkowitz, who also leads the Wall

Street giant's Institutional Securities Group.

(Reporting by Tatiana Bautzer in New York and Arasu Kannagi

Basil in Bengaluru, editing by Lananh Nguyen

)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MRC Global Extends Asset-Based Revolving Loan
MRC Global Extends Asset-Based Revolving Loan
Nov 13, 2024
06:43 AM EST, 11/13/2024 (MT Newswires) -- MRC Global ( MRC ) said late Tuesday it has amended its asset-based revolving loan facility, with a $750 million borrowing capacity, to extend maturity through November 2029. The asset-based loan facility has a borrowing rate of term secured overnight financing rate plus a margin of 1.25% to 1.75%, the company added. ...
Enlight Renewable Energy's Q3 Earnings Fall, Revenue Rises; 2024 Revenue Guidance Lifted
Enlight Renewable Energy's Q3 Earnings Fall, Revenue Rises; 2024 Revenue Guidance Lifted
Nov 13, 2024
06:40 AM EST, 11/13/2024 (MT Newswires) -- Enlight Renewable Energy ( ENLT ) reported Q3 diluted earnings Wednesday of $0.12 per share, down from $0.13 a year earlier. Two analysts polled by Capital IQ expected $0.01. Revenue for the quarter ended Sept. 30 was $109.5 million, up from $58.3 million a year earlier. Three analysts surveyed by Capital IQ expected...
Gyre Therapeutics Q3 Earnings, Revenue Decline
Gyre Therapeutics Q3 Earnings, Revenue Decline
Nov 13, 2024
06:42 AM EST, 11/13/2024 (MT Newswires) -- Gyre Therapeutics ( GYRE ) reported Q3 earnings Wednesday of $0.01 per diluted share, down from $0.05 a year earlier. Revenue for the quarter ended Sept. 30 was $25.5 million, down from $32 million a year earlier. Analysts' estimates were not readily available for comparison. ...
Exclusive-Glencore-Chandra Singapore refinery to earmark 20% of output for Shell, sources say
Exclusive-Glencore-Chandra Singapore refinery to earmark 20% of output for Shell, sources say
Nov 13, 2024
SINGAPORE (Reuters) - Glencore ( GLCNF ) and Chandra Asri, gearing up to complete their takeover of Shell's landmark Singapore refinery, have set up a new operating company and will earmark roughly 20% of output for the plant's outgoing owner, sources familiar with the matter said. The venture has lined up long-term crude supply from Abu Dhabi National Oil Co...
Copyright 2023-2026 - www.financetom.com All Rights Reserved